Skip to main content
logo
Libo Pharma Corp. (TPEX:7888)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.90
-0.90 (-3.02%)
At close: Sep 2, 2026

Libo Pharma Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-363.1-296.3-147.8-46.41
Depreciation & Amortization
23.4323.2317.574.89
Other Amortization
0.430.320.10.12
Stock-Based Compensation
31.5421.6123.60.5
Other Operating Activities
-1.77-1.11-0.2-3.17
Change in Accounts Receivable
0.280.060.233.61
Change in Accounts Payable
-2.0713.24-1.034.19
Change in Other Net Operating Assets
-134.87-110.15-10.940.31
Operating Cash Flow
-446.12-349.1-118.47-35.96
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
-0.69-0.56-1.36-0.05
Sale (Purchase) of Intangibles
--0.44-172.24-0.17
Investment in Securities
---44.45
Other Investing Activities
-00.03-0.08-
Investing Cash Flow
-0.69-0.97-173.6844.23

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Long-Term Debt Repaid
--1.66-1.15-1.05
Net Debt Issued (Repaid)
-1.58-1.66-1.15-1.05
Issuance of Common Stock
752.73877.33493.471.08
Financing Cash Flow
751.16875.67492.320.03

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Cash Flow
304.35525.6200.168.3

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-446.8-349.66-119.84-36.01
Free Cash Flow Growth
----
Free Cash Flow Per Share
-6.00-5.59-2.56-1.36
Levered Free Cash Flow
-320.4-246.01-239.68-
Unlevered Free Cash Flow
-320.38-245.99-239.65-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Cash Interest Paid
0.030.040.050.07
Cash Income Tax Paid
1.050.390.20.23
Change in Working Capital
-136.65-96.84-11.738.11